Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03800030 · ClinicalTrials.gov registry record · NA
Effect of Cross Frequency tACS on Cognitive Control
A NA study of Executive Function and Cognitive Control, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT03800030: Completed NA study of Executive Function and Cognitive Control, sponsored by University of North Carolina, Chapel Hill.
NCT03800030 is a NA study of Executive Function and Cognitive Control that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 26 participants, below the 144-participant average among 5 other Executive Function trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03800030, a NA study of Executive Function and Cognitive Control, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigation of frequency specific transcranial alternating current stimulation on cognitive control signals in frontal cortex
Primary Outcome
For low abstraction conditions, subjects must memorize a color to button mapping. For high abstraction conditions, subject must make a perceptual judgement on the similarity of two objects based on either texture or shape as cued by a color. The reaction time difference between high and low abstraction conditions was hypothesized to decrease when delta-beta tACS was delivered. As a control for the placebo effect of stimulation, the difference between delta-beta tACS and sham tACS, or placebo, wa
Conditions Studied
Interventions
- DEVICE Sham tACS
- DEVICE Theta-gamma tACS
- DEVICE Delta-beta tACS
Study Locations (1)
North Carolina
- University of North Carolina, Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-10-07 |
| Est. Completion | 2019-07-25 |
| Phase | NA |
What the finished NCT03800030 record still lists
NCT03800030 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 144-participant average among 5 other Executive Function trials with a reported enrollment target (82% lower).
The record links to 2 conditions, with Executive Function appearing as the primary indexed condition, and to 3 interventions - of which Sham tACS is the first listed.
NCT03800030 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03800030 about?
NCT03800030 is a clinical study titled "Effect of Cross Frequency tACS on Cognitive Control". Investigation of frequency specific transcranial alternating current stimulation on cognitive control signals in frontal cortex
What is the current status of trial NCT03800030?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-10-07. Estimated completion is 2019-07-25.
What conditions does trial NCT03800030 study?
This clinical trial studies the following conditions: Executive Function, Cognitive Control.
What interventions are being tested in trial NCT03800030?
The interventions under investigation include: Sham tACS (DEVICE), Theta-gamma tACS (DEVICE), Delta-beta tACS (DEVICE).
Who is sponsoring clinical trial NCT03800030?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03800030 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Executive Function
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Investigation of Attentional and Inhibitory Processes During Active Visual Search in Humans
RECRUITING · NA
-
SCREENS: Sleep, Circadian Rhythms, and Electronics in the EveNing Study
RECRUITING · NA
-
Executive Function and Parenting in Childhood
RECRUITING · NA
-
Cognitive Control & the Functional Organization of the Frontal Cortex
RECRUITING · NA
-
Cognitive Aspects of Response to Treatment for Weight-related Health to Improve Eating and Exercise Earlier in Life
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI